New Ray Medicine International : Results of AGM / Share Option Scheme / Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

New Ray Medicine International Holding Limited

新銳醫藥國際控股有限公司

(Incorporated in Bermuda with limited liability)

(Stock Code: 6108)

1. POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2017;
2. RETIREMENT OF DIRECTORS;
3. APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND
4. CHANGE IN COMPOSITION OF AUDIT COMMITTEE,

REMUNERATION COMMITTEE, NOMINATION COMMITTEE AND CORPORATE GOVERNANCE COMMITTEE POLL RESULTS OF ANNUAL GENERAL MEETING

The Board is pleased to announce that at the AGM held on 20 June 2017, the Resolutions were duly passed as ordinary resolutions of the Company by the Shareholders by way of poll.

RETIREMENT OF DIRECTORS

The Board announces that Mr. Lee Chik Yuet and Mr. Sung Hak Keung, Andy retired as an executive Director and an independent non-executive Director at the conclusion of the AGM held on 20 June 2017 respectively.

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board further announces that with effect from 20 June 2017 after the conclusion of the AGM, Ms. Li Sin Ming, Ivy has been appointed as an independent non-executive Director.

CHANGE IN COMPOSITION OF AUDIT COMMITTEE, REMUNERATION COMMITTEE, NOMINATION COMMITTEE AND CORPORATE GOVERNANCE COMMITTEE

Following the retirement of Mr. Lee as an executive Director, he ceased to be the chairman of the CG Committee. Following the retirement of Mr. Sung as an independent non-executive Director, he ceased to be the chairman of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee. With effect from 20 June 2017, Ms. Li was appointed as the chairman of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee.

Reference is made to the circular ("Circular") and notice ("Notice") of the annual general meeting ("AGM") of New Ray Medicine International Holding Limited ("Company") dated 18 May 2017. Unless otherwise specified, capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.

POLL RESULTS OF ANNUAL GENERAL MEETING

The Board is pleased to announce that at the AGM held on 20 June 2017, all the resolutions as set out in the Notice ("Resolutions") were duly passed as ordinary resolutions of the Company by the Shareholders by way of poll.

As at the date of the AGM, there were a total of 1,665,792,000 Shares in issue. To the best of the Directors' knowledge, information and belief having made all reasonable enquiries, no Shareholder had material interest in the Resolutions and was required to abstain from voting on any of the Resolutions at the AGM in accordance with the Listing Rules. None of the Shareholders was entitled to attend and abstain from voting in favour of any of the Resolutions proposed at the AGM according to Rule 13.40 of the Listing Rules. None of the Shareholders stated his/her/its intention in the Circular to vote against any of the Resolutions or to abstain from voting at the AGM. As such, there were a total of 1,665,792,000 Shares, representing 100% of the issued share capital of the Company as at the date of the AGM, entitling holders thereof to attend and vote on the Resolutions proposed at the AGM.

The full text of the Resolutions was set out in the Notice, a copy of which is set out in the Circular. The poll results for the Resolutions were as follows:

Ordinary Resolutions		Number of Shares (%)
		For	Against
1.	To receive and approve the audited consolidated financial statements of the Company and its subsidiaries and the reports of the Directors and auditors of the Company for the year ended 31 December 2016.	878,876,488 (100%)	0 (0%)
2.	(a) To re-elect Mr. Ho Hau Cheung, BBS, MH as an independent non-executive Director.	878,876,488 (100%)	0 (0%)
	(b) To re-elect Mr. Leung Chi Kin as an independent non-executive Director.	878,876,488 (100%)	0 (0%)
	(c) To authorise the Board to fix the Directors' remuneration.	878,876,488 (100%)	0 (0%)
3.	To re-appoint Deloitte Touche Tohmatsu as the Company's auditors and authorise the Board to fix its remuneration.	878,876,488 (100%)	0 (0%)
4.	To grant a general mandate to the Directors to issue, allot or otherwise deal with the Company's shares.	878,876,488 (100%)	0 (0%)
5.	To grant a general mandate to the Directors to repurchase the Company's shares.	878,876,488 (100%)	0 (0%)
6.	To extend the general mandate granted to the Directors to allot, issue or deal with the Company's shares by the number of shares repurchased.	878,876,488 (100%)	0 (0%)
7.	To approve the refreshment of the 10% general limit of the share option scheme of the Company.	878,876,488 (100%)	0 (0%)

Notes: The number of votes and percentage of the voting as stated above are based on the total number of Shares held by the Shareholders who attended and voted at the AGM in person, by authorised corporate representative or by proxy.

As more than 50% of the votes were cast in favour of the Resolutions, the Resolutions were duly passed as ordinary resolutions of the Company by the Shareholders without modification at the AGM.

Tricor Investor Services Limited, the branch share registrar and transfer office of the Company in Hong Kong, was appointed as the scrutineer for the vote-taking at the AGM.

RETIREMENT OF DIRECTORS

Mr. Lee Chik Yuet ("Mr. Lee") has retired as an executive Director and ceased to be the chairman of the corporate governance committee of the Board ("CG Committee") with effect from the conclusion of the AGM. Mr. Lee retired from the Board and did not offer himself for re-election in order to focus on his own personal business which requires more of his time and dedication. Mr. Lee has confirmed to the Board that he has no disagreement with the Board and there are no matters in relation to his retirement that needs to be brought to the attention of the Shareholders. The Board is also not aware of any such matters in relation to the retirement of Mr. Lee that need to be brought to the attention of the Shareholders.

Mr. Sung Hak Keung, Andy ("Mr. Sung") has retired as an independent non-executive Director and ceased to be the chairman of the audit committee of the Board ("Audit Committee") and a member of the remuneration committee ("Remuneration Committee") and the nomination committee ("Nomination Committee") of the Board with effect from the conclusion of the AGM. Mr. Sung retired from the Board and did not offer himself for re-election in order to focus on his own personal business which requires more of his time and dedication. Mr. Sung has confirmed to the Board that he has no disagreement with the Board and there are no matters in relation to his retirement that needs to be brought to the attention of the Shareholders. The Board is also not aware of any such matters in relation to the retirement of Mr. Sung that need to be brought to the attention of the Shareholders.